From Wikipedia, the free encyclopedia
Therapeutic monoclonal antibody
11 ± 4 days
℞ Prescription only
Natalizumab is a prescription drug co-marketed by Biogen Idec and Élan as Tysabri. It was previously named Antegren. Natalizumab is administered by infusion and has proven effective in the treatment of multiple sclerosis and Crohn's disease. Three months after its approval by the FDA, the drug was voluntarily withdrawn after being linked to adverse events including one death. After an intensive safety evaluation, the drug was re-approved by the FDA as a potentially significant advancement over existing therapies and returned to the marketplace under a program of restricted distribution and regular patient evaluations.
Holly is on the left, and kandace's forehead is on the right. We had a good time talking and getting and giving the D.L. on whats been going on in everyones lives. It was bunches of fun.